These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1151 related articles for article (PubMed ID: 27809538)

  • 1. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
    Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
    Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
    Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
    Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study.
    Shin S; Kim TH; Lee DY; Chung SE; Lee JB; Kim DH; Shin BS
    AAPS J; 2020 Jan; 22(2):27. PubMed ID: 31938935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Relevant In Vitro-In Vivo Correlation (IVIVC) Approach for Sildenafil with Site-Dependent Dissolution.
    Kim TH; Shin S; Jeong SW; Lee JB; Shin BS
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J; Amidon GL; Langguth P
    Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
    Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Level a In Vitro-In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study.
    Lee DY; Shin S; Kim TH; Shin BS
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.
    Shin S; Kim TH; Jeong SW; Chung SE; Lee DY; Kim DH; Shin BS
    PLoS One; 2019; 14(5):e0216875. PubMed ID: 31091273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
    Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
    J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a level A in vitro-in vivo correlation for extended release dosage forms of quetiapine fumarate.
    Gonçalves de Lima L; Rossi de Campos D
    Drug Res (Stuttg); 2016 May; 66(5):225-9. PubMed ID: 26697891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.
    Kesisoglou F; Rossenu S; Farrell C; Van Den Heuvel M; Prohn M; Fitzpatrick S; De Kam PJ; Vargo R
    J Pharm Sci; 2014 Nov; 103(11):3713-3723. PubMed ID: 25256703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation variation and in vitro-in vivo correlation for a rapidly swellable three-layered tablet of tamsulosin HCl.
    Park JS; Shim JY; Park JS; Lee MJ; Kang JM; Lee SH; Kwon MC; Choi YW; Jeong SH
    Chem Pharm Bull (Tokyo); 2011; 59(5):529-35. PubMed ID: 21532187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case Study.
    Kim S; Sharma VD; Lingineni K; Farhan N; Fang L; Zhao L; Brown JD; Cristofoletti R; Vozmediano V; Ait-Oudhia S; Lesko LJ; Trame MN; Schmidt S
    J Clin Pharmacol; 2019 Sep; 59(9):1266-1274. PubMed ID: 31087554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.